"Atrium Health Stanly is a 119-bed hospital in Albemarle, NC, offering advancements in cancer treatment, imaging, rehabilitation, women's services and more."

During the past decade, Atrium Health Stanly/LCI-Albemarle conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atrium Health Stanly/LCI-Albemarle" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "NRG Oncology" with 3 trials sponsored, "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health Stanly/LCI-Albemarle" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Donaghue Medical Research Foundation" with 1 trials as a collaborator and "Sky Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health Stanly/LCI-Albemarle" are "Colon Adenocarcinoma" (3 trials), "Invasive Breast Carcinoma" (3 trials), "Extensive Stage Lung Small Cell Carcinoma" (2 trials), "Rectal Adenocarcinoma" (2 trials) and "Stage III Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Atrium Health Stanly/LCI-Albemarle" in a lesser frequency.

Most popular intervention types in "Atrium Health Stanly/LCI-Albemarle" are "Drug" (18 trials), "Other" (16 trials), "Procedure" (13 trials), "Biological" (12 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (10 trials), "Biospecimen Collection" (9 trials), "Computed Tomography" (8 trials), "Magnetic Resonance Imaging" (8 trials) and "Atezolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health Stanly/LCI-Albemarle" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Atrium Health Stanly/LCI-Albemarle". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Atrium Health Stanly/LCI-Albemarle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health Stanly/LCI-Albemarle, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".